Kenvue, adding three directors, solves the proxy battle with activist starboard

Ram Adding a three new director to the board, the activist solved the proxy battle with the starboard value.

Will join the Starboard’s Jeff Smith board Johnson & Johnson Spinoff, along with Sarah Hofstetter, Profitero President, e-commerce performance analytical platform and Erica Mann, former head of the Perfacutical Society Bayerin Consumer health department.

“Sarah’s brand building and digital marketing expertise, Erica’s global consumer industry experience and Jeff will further strengthen the board with extensive services on investor and corporate boards,” he said, “he said,” he said statement Wednesday.

CNBC reported that this starboard in October collected a significant share The company’s disappointment and price performance was distributed.

Kenvue is a manufacturer of widespread brands familiar with both investors, investors, both investors, listerin, Neutrogena, Neutrogena, Tylenol and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J and J.

J & J completed the separation from Kenvue in August 2023, and since then, the consumer sold the whole share in the giant. This noted the largest shake in the history of J & J about 140 years.